BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6258534)

  • 1. [Autoantibodies in glioblastoma multiforme (author's transl)].
    Roda JE; Heredero JJ; Villarejo FJ; Roda JM
    Arch Neurobiol (Madr); 1980; 43(6):377-90. PubMed ID: 6258534
    [No Abstract]   [Full Text] [Related]  

  • 2. Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells.
    Tang J; Flomenberg P; Harshyne L; Kenyon L; Andrews DW
    Clin Cancer Res; 2005 Jul; 11(14):5292-9. PubMed ID: 16033848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemistry of brain tumor--brain tumor protein and immune reactions (author's transl)].
    Takakura K
    No Shinkei Geka; 1974 Oct; 2(10):655-61. PubMed ID: 4373672
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunology of brain tumors: the glial carcino-fetal antigen].
    Trouillas P
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):819-28. PubMed ID: 4340548
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunology and immunotherapy of cerebral tumors. Current status].
    Trouillas P
    Rev Neurol (Paris); 1973 Jan; 128(1):23-38. PubMed ID: 4367367
    [No Abstract]   [Full Text] [Related]  

  • 6. Primary brain tumors: tumor immunity and immunocompetence.
    Mavligit GM; Gutterman JU; Hersh EM
    Surg Neurol; 1973 Sep; 1(5):261-3. PubMed ID: 4353433
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival.
    Pallasch CP; Struss AK; Munnia A; König J; Steudel WI; Fischer U; Meese E
    Int J Cancer; 2005 Nov; 117(3):456-9. PubMed ID: 15906353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses in patients with gliomas.
    Brooks WH; Caldwell HD; Mortara RH
    Surg Neurol; 1974 Nov; 2(6):419-23. PubMed ID: 4372736
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of immunologic studies in malignant tumors of the human brain].
    Romodanov AP; Lisianyĭ NI; Prikhodchenko IA
    Zh Vopr Neirokhir Im N N Burdenko; 1983; (3):56-9. PubMed ID: 6310917
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunohistochemical study of the expression of proliferating cell nuclear antigen in astrocytic gliomas of the cerebral hemispheres].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1996; 58(2):32-7. PubMed ID: 8712938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific membrane antigens in established cell lines from gliomas.
    Wahlström T; Linder E; Saksela E; Westermark B
    Cancer; 1974 Aug; 34(2):274-9. PubMed ID: 4369403
    [No Abstract]   [Full Text] [Related]  

  • 12. Why are systemic glioblastoma metastases rare? Systemic and cerebral growth of mouse glioblastoma.
    Mourad PD; Farrell L; Stamps LD; Chicoine MR; Silbergeld DL
    Surg Neurol; 2005 Jun; 63(6):511-9; discussion 519. PubMed ID: 15936366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Extracranial metastasis of the glioblastoma multiforme--an ultrastructural studies (author's transl)].
    Shimura T; Itoh Y; Nakazawa S; Yamada N; Aihara K
    No To Shinkei; 1980 Jun; 32(6):601-9. PubMed ID: 6257263
    [No Abstract]   [Full Text] [Related]  

  • 14. Two specific antigens in glioblastoma multiforme identified by monoclonal antibodies.
    Sharma SK; Kochhar KS; Sharma E; Thapliyal RM; Singh UN
    Indian J Biochem Biophys; 1988; 25(1-2):185-92. PubMed ID: 2846427
    [No Abstract]   [Full Text] [Related]  

  • 15. Soluble membrane antigens of brain tumors. I. Controlled testing for cell-mediated immune responses in a long surviving glioblastoma multiforme patient.
    Hitchcock MH; Hollinshead AC; Chretien P; Rizzoli HV
    Cancer; 1977 Aug; 40(2):660-6. PubMed ID: 196738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glial tumors of the brain: current aspects of the immunopathogenesis and immunogenodiagnosis].
    Anan'eva II; Malkarov MS; Korsakova NA; Dorofeev AE; Kachkov IA; Suchkov SV; Balkanov AS
    Arkh Patol; 2007; 69(2):53-7. PubMed ID: 17642197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.
    Yu JS; Wheeler CJ; Zeltzer PM; Ying H; Finger DN; Lee PK; Yong WH; Incardona F; Thompson RC; Riedinger MS; Zhang W; Prins RM; Black KL
    Cancer Res; 2001 Feb; 61(3):842-7. PubMed ID: 11221866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock proteins in glioblastomas.
    Yang I; Fang S; Parsa AT
    Neurosurg Clin N Am; 2010 Jan; 21(1):111-23. PubMed ID: 19944971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems peculiar to brain malignancies.
    Ramamurthi B
    Indian J Cancer; 1972 Sep; 9(3):249-50. PubMed ID: 4347920
    [No Abstract]   [Full Text] [Related]  

  • 20. [Frequency and significance of lymphoplasmocyte infiltration in human gliomas (author's transl)].
    Schiffer D; Croveri G; Pautasso C
    Tumori; 1974; 60(3):177-84. PubMed ID: 4372756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.